● At closeAs of Jul 3, 2026
Zhejiang Jingxin Pharmaceutical Co., Ltd.
SHE: 002020✓$2.24CN¥15.19+3.62%
$1.93BMarket cap
-P/E ratio
63.06MVolume (24h)
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
 Eli Lilly and CompanyLLY | $1.14T | 42.53x | 15.63x | 34.89x | 0.54% |
 Johnson & JohnsonJNJ | $633.20B | 29.29x | 6.34x | 19.25x | 2.06% |
 AbbVie Inc.ABBV | $461.26B | 123.28x | 7.07x | 30.00x | 2.68% |
 UnitedHealth Group IncorporatedUNH | $386.29B | 31.34x | 0.84x | 18.59x | 2.15% |
 Roche Holding AGSWX: ROP | $335.52B | 20.90x | 4.38x | 13.10x | 2.90% |
 Merck & Co., Inc.MRK | $319.89B | 36.07x | 4.84x | 19.22x | 2.62% |
| Zhejiang Jingxin Pharmaceutical Co., Ltd.SHE: 002020 | $1.93B | - | - | - | - |